Clinical Trial Update: A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating INNA-051 for prevention of viral respiratory illnesses in healthy adults aged 18-45; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Respiratory Illness
• Viral Respiratory Infection

Drugs mentioned

• INNA-051

Snippet

Sponsor: ENA Respiratory Pty Ltd | Conditions: Viral Respiratory Infection, Viral Respiratory Illnesses | Phase 2 | Status: RECRUITING